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In vivo and in vitro evaluation of flexible, cottonwool-like
nanocomposites as bone substitute material for complex defects
Abstract
The easy clinical handling and applicability of biomaterials has become a focus of materials research
due to rapidly increasing time and cost pressures in the public health sector. The present study assesses
the in vitro and in vivo performance of a flexible, mouldable, cottonwool-like nanocomposite based on
poly(lactide-co-glycolide) and amorphous tricalcium phosphate nanoparticles (PLGA/TCP 60:40).
Immersion in simulated body fluid showed exceptional in vitro bioactivity for TCP-containing fibres
(mass gain: 18%, 2 days, HAp deposition). Bone regeneration was quantitatively investigated by
creating four circular non-critical-size calvarial defects in New Zealand White rabbits. The defects were
filled with the easy applicable cottonwool-like PLGA/TCP fibres or PLGA alone. Porous
bovine-derived mineral (Bio-Oss) was used as a positive control and cavities left empty served as a
negative control. The area fraction of newly formed bone (4 weeks implantation) was significantly
increased for TCP-containing fibres compared to pure PLGA (histological and micro-computed
tomographic analysis). A spongiosa-like structure of the newly formed bone tissue was observed for
PLGA/TCP nanocomposites, whereas Bio-Oss-treated defects afforded a solid cortical bone.
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Abstract 
Easy clinical handling and applicability of biomaterials has shifted into the focus of 
material’s research through the rapidly increasing time and cost pressure in the public 
health sector. The present study assesses the in vitro and in vivo performance of a 
flexible, moldable, cotton-wool like nanocomposite based on poly(lactide-co-
glycolide) and amorphous tricalcium phosphate nanoparticles (PLGA/TCP 60:40). 
Immersion in simulated body fluid showed exceptional in vitro bioactivity for TCP 
containing fibres (mass gain: 18%, 2 d, HAp deposition). Bone regeneration was 
quantitatively investigated by creating four circular non critical-size calvarial defects 
in New Zealand White rabbits. The defects were filled with the easy applicable cotton 
wool-like PLGA/TCP fibres or PLGA alone. Porous bovine-derived mineral (Bio-
Oss®) was used as a positive control and cavities left empty served as a negative 
control. The area fraction of newly formed bone (4 weeks implantation) was 
significantly increased for TCP containing fibres if compared to pure PLGA 
(histological and micro computed tomography analysis). A spongiosa-like structure of 
the newly formed bone tissue was observed for PLGA/TCP nanocomposites whereas 
Bio-Oss® treated defects afforded a solid cortical bone. 
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1. Introduction 
The use of bone substitute material for non-load bearing operation sites has recently 
experienced increased interest. Such materials find application in oral and 
maxillofacial surgery. Two properties determine the success of a bone graft: Its 
handling properties in the operation room and its performance in vivo i.e. formation of 
new bone. An easy handling generally safes time and minimizes complications during 
surgery and therefore reduces cost. An uncomplicated, fast post-operative healing 
means less stress and less cost for the patient. Autogeneous bone [1, 2] (taken from 
iliac crest, ribs or calvarium) is frequently used for the repair of bone defects. 
However, besides of its limited availability, its use often results in significant donor 
site morbidity [3], requirement of a second surgical site, potential risk of viral or 
bacterial infections [4] and of an immune response of the host tissue after 
implantation. Therefore, artificial bone substitutes are being developed [5-11]. 
Preferably, these materials are bioactive for spontaneous bone bonding in the living 
body, otherwise the implant may be surrounded by fibrous tissue and encapsulated, in 
the worst case leading to device failure and explantation. Additionally the bone 
substitute should be resorbed and gradually replaced by newly formed bone [12]. 
Different types of bioactive materials, mainly ceramics, have been developed over the 
last years and are clinically used in the form of hydroxyapatite (HAp), tricalcium 
phosphate (TCP), HAp/TCP bi-phase ceramics and bioactive glass. Calcium 
phosphates are osteoconductive [13, 14] and support the attachment, differentiation 
and proliferation of osteoblasts as investigated in vitro and in vivo. Additionally they 
have an excellent biocompatibility due to their close chemical and crystal similarity to 
natural bone mineral [15]. The greatest limitation of pure ceramic biomaterials is their 
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brittleness, incompressibility and difficulty to fill irregularly shaped bone defects 
during surgery.  
The incorporation of ceramics in biodegradable and bioresorbable polymers has been 
investigated previously to improve the ductility and mechanical properties of the 
biomaterial [16]. Poly(lactide-co-glycolide) (PLGA) is a well established FDA (Food 
and Drug Administration) approved [17] biodegradable synthetic copolymer for 
scaffolds in tissue engineering [18] that allows resorption over time and regeneration 
of biological tissue. Suitable 3D scaffolds require an interconnected porosity of > 
90% to direct the cells in tissue growth and vascularization [19, 20]. Electrospinning 
[21] is a simple process that offers ultrafine polymer fibres having a high specific 
surface area. Modified to low-temperature electrospinning [22] this method enables 
access to scaffolds with high porosities. 
The beneficial use of ceramics in a nanoparticluate form as fillers in biopolymers has 
been demonstrated in numerous investigations: Misra et al. have compared nanoscale 
and microscale bioactive glass in poly(3-hydroxybutyrate) films prepared by solvent 
casting and showed increased in vitro bioactivity, mechanical properties and protein 
adsorption for the nanocomposite [23]. Nanofibrous electrospun scaffolds consisting 
of biodegradable polycaprolactone, hydroxyapatite and natural polymer gelatine 
provided a large surface area for cell attachment, proliferation and mineralization 
[24]. Amorphous TCP has been shown to exhibit high in vitro bioactivity [25, 26] and 
increased solubility and reactivity attributed to its high enthalpy of formation [27]. In 
a recent study [28, 29] an electrospun nanocomposite containing amorphous TCP 
exhibited a high in vitro bioactivity, cell proliferation and osteogenic differentiation 
of human mesenchymal stem cells. 
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The present study investigates a combination of these advantageous material 
properties in the form of a cotton wool-like, amorphous TCP containing PLGA 
scaffold prepared by low-temperature electrospinning. The potential of this bone 
substitute for clinical application in repairing non-load bearing bone defects as they 
occur in dental, oral and maxillofacial surgery was tested. In vivo bone regeneration 
was investigated by creating four circular non critical-size calvarial defects in New 
Zealand White rabbits [30] which were filled with the easy to apply electrospun 
PLGA/TCP fibres or PLGA fibres alone. As the “gold standard” in bone substitution, 
a porous bovine-derived mineral (Bio-Oss®) was used as a positive control, cavities 
left empty served as a negative control. Histology and micro computed tomography 
were performed to evaluate the formation of new bone. The goal of the present study 
was to show the first in vivo performance of a flexible, moldable and highly bioactive 
calcium phosphate/PLGA nanocomposite. 
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2. Materials and Methods 
2.1. Preparation of TCP particles 
X-ray amorphous tricalcium phosphate nanoparticles (TCP, chemical formula: 
Ca3(PO4)2) were prepared by flame spray synthesis using calcium hydroxide (Riedel 
de Haen, Ph. Eur.) dissolved in 2-ethylhexanoic acid (Fluka, puriss) and tributyl 
phosphate (Fluka, puriss) as precursors [31-33]. The liquid mixture with a molar ratio 
of Ca/P = 1.5 was diluted with toluene (Fluka, puriss) (2:1 vol/vol) and fed through a 
capillary (diameter 0.4 mm) into a methane/oxygen flame at a rate of 5 ml min-1. 
Oxygen (5 L min-1, 99.8%, Pan Gas) was used to disperse the liquid leaving the 
capillary and resulted in a burning spray of about 10 cm height. The as-formed 
particles (production rate: 8 g h-1) were collected on a teflon filter (25.7 cm diameter, 
Tulona needle felt-PTFE-membrane), placed on a cylinder mounted above the flame, 
by the aid of a vacuum pump (Busch Seco SV 1040 C). As a gold standard for bone 
regeneration bovine bone mineral (Bio-Oss®) was donated by Geistlich (Wohlhusen, 
Switzerland). 
 
2.2. Particle characterization 
The specific surface area (SSA) of the TCP powder was measured by nitrogen 
adsorption at 77 K according to the Brunauer-Emmett-Teller (BET) method after 
outgassing at 150 °C for 1h. The primary particle diameter was calculated according 
to dBET = 6/(ρTCP·SSA) assuming spherical particles, whereas the density of TCP 
equals 3.14 g cm-3. For Fourier transform infrared (FTIR) spectroscopy, 1% (w/w) of 
powder was mixed with KBr (Fluka, puriss) and examined on a Tensor 27 
spectrometer (Bruker Optics, 4000 cm-1 < λ < 400 cm-1, 16 scans, 4 cm-1 resolution) 
equipped with a diffusive reflectance accessory (DiffusIRTM, Pike Technologies). X-
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ray diffraction (XRD) patterns were collected on a Stoe STADIP2 (Ge 
monochromator, Cu Kα1, PSD detector). Transmission electron microscopy (TEM) 
images were recorded on a CM30 ST (Philips, LaB6 cathode, operated at 300 kV, 
point resolution ~4 Å). Particles were deposited onto a carbon foil supported on a 
copper grid. 
 
2.3. Scaffold preparation 
Clinically approved poly(lactide-co-glycolide) (PLGA) with a copolymer ratio of 
85:15 (Resomer® Sample MD Type RG) was purchased from Boehringer Ingelheim 
with a weight and number average molecular weight of 380’300 g mol-1 and 181’900 
g mol-1, respectively. Randomly oriented pure PLGA and 40 wt% TCP containing 
PLGA fibres were fabricated by low-temperature electrospinning [22], a process that 
is slightly modified from common electrospinning [21, 34] and enables to produce 
scaffolds with high porosities. Both electrospinning solutions were prepared with a 
concentration of 7% (w/w) PLGA in chloroform (Riedel de Haen, Ph. Eur.) 
containing 5% (w/w) of the surfactant Tween20 (Polysorbate20, Fluka, Ph. Eur.) 
referred to the polymer. For the preparation of the electrospinning solution, TCP 
nanoparticles were first dispersed in a chloroform/Tween20 mixture using an 
ultrasonic processor at 320 W for 7 min applying pulsed intervals to allow for 
relaxation of the particles. PLGA was subsequently added and dissolved for 15 h by 
magnetic stirring. The electrospinning solutions were fed through a capillary (inner 
diameter 1.0 mm) using a syringe pump. The feeding rate was set to 2 ml h-1 for 
PLGA/TCP 60/40 and 4 ml h-1 for the pure PLGA solutions. A high voltage supply 
was used to apply voltages of 20 kV to the needle tip. A coaxial jacket of chloroform 
saturated air prevented the needle exit form clogging by suppressing excessive solvent 
 -8- 
evaporation as proposed by Larsen et al. [35]. A positively charged jet was formed 
from the Taylor cone and was sprayed onto a rotating (130 rpm) collection drum 
covered by aluminium foil. The drum was loaded with dry ice (frozen CO2; average 
temperature 195 K) which caused rapid deposition of ice crystals at the cold external 
cylinder surface on which the fibres were collected. The distance between the needle 
tip and the collection tube (diameter 8 cm) was kept at 10 cm for PLGA/TCP 60/40 
and 20 cm for pure PLGA samples. Immediately after electrospinning the as-spun 
scaffolds were transfered to a vacuum oven (50 mbar, RT, 12 h). 
 
2.4. Scaffold characterization 
The morphology of the electrospun fibres was characterized using scanning electron 
microscopy (SEM; LEO 1530 Gemini) at a voltage of 3 kV after sputtering the 
samples with a 4 nm platinum layer. The porosities of the scaffolds were calculated 
according to ε = (Vtot-Vsolid)/Vtot, whereas the total volume (Vtot) was determined from 
the base area of the sample and its thickness as measured by SEM. The solid volume 
(Vsolid) is given by the sample mass and its bulk density calculated from the density of 
PLGA (ρPLGA = 1.2 g cm-3) and TCP (ρTCP = 3.14 g cm-3). 
 
2.5. In vitro biomineralization in simulated body fluid 
Electrospun PLGA and TCP containing nanocomposite scaffolds were cut into 
rectangles (70  10 mm2) for in vitro degradation tests. After sterilization by UV 
irradiation (50W m-2, 2h) [36], the samples were placed in 250 ml simulated body 
fluid (SBF, pH 7.4) and incubated for 49 h at 37°C. SBF was prepared according to 
Kokubo et al. [37] and sterile-filtered through a presterilized filter unit (Millipore, 
0.22μm). Sterile conditions guaranteed that no bacterial or fungal degradation resulted 
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in polymer dissolution. After immersion in SBF, the samples were washed with 
Millipore water, dried for 24 h in an evacuated exsiccator at room temperature before 
SEM images were recorded. A more detailed study on the in vitro biomineralization 
of these nanocomposites may be found in Ref [28]. 
 
2.6. In vivo study in New Zealand white rabbits 
For the in vivo study PLGA and PLGA/TCP scaffolds were portioned and UV-
sterilized (50W m-2, 2h). Nine New Zealand white rabbits were used for the study, 
which was approved by the local Ethical Committee. The rabbits were sedated by 
Ketamin and further anaesthetized by a Halothan-N2O inhalation method. The 
surgical area was clipped and prepared with iodine for aseptic surgery. A linear 
incision was made from the nasal bone to the midsagital crest. The soft tissues were 
reflected and the periosteum was dissected from the site (occipital, frontal, and 
parietal bones). Four 6 mm craniotomy defect were created (2 in the parietal and 2 in 
the frontal bone) with a 6 mm trephine in a dental hand piece. The surgical area was 
flushed with saline act as a coolant and to remove bone debris. To avoid any dural 
perforation, the defects marked half way through the bone by the trephine were finally 
made by a round blur creating a 6 mm defect. In each animal, one untreated defect 
was compared to one defect treated with Bio-Oss® (Geistlich, Wolhusen, 
Switzerland), one treated with PLGA and one treated with PLGA/TCP 60:40 
scaffolds. After placement of the materials, the soft tissues were closed with sutures. 
Analgesia was provided by injection of Novalgin (50 mg/kg). Four weeks following 
the surgery, the rabbits were sacrificed to harvest the calvarial bone after sedation 
with barbiturates by an overdose of Ketamin. 
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2.7. Radiography and histology 
Specimens were radiographed using a dental radiography unit with ultra speed dental 
films (Eastman Kodak Company, NY, USA). The radiographs were photographed, 
scanned and later used to localize the middle section of the defects. After radiography, 
the samples were first prepared with a sequential water substitution process that 
involved 48 h in 40% ethanol, 72 h in 70% ethanol (changed 24 h). At this step the 
µCT scan was performed. Following µCT the sequential water substitution was 
continued by placing the samples 72 h in 96% ethanol and finally 72 h in 100% 
ethanol. Following the water substitution, samples were placed in xylene for 72 h for 
defatting the recovered bone (changed every 24 h). Next, infiltration was performed 
by placing the samples in methyl methacrylate (MMA) for 72 h (Fluka, purum) 
followed by three days in 100 ml MMA + 2 g di-benzoylperoxide (Fluka, purum), at 
4 °C. Samples were embedded by placing them in 100 ml MMA + 3 g di-
benzoylperoxide + 10 ml plastoid N or dibutylphtalate (Merck, for synthesis) and 
allowing polymerization to occur at 37 °C in an air tight water bath. 4.5 µm sections 
were prepared from the midst of the defects and stained with Goldner Trichrome. 
Digital images were taken with an image analysis program (Adobe Photoshop). 
 
2.8. Histomorphometry 
Quantitative evaluation of bone regeneration was assessed in the middle section by 
determining the percentage of bone within the former defect area. Measurements were 
carried out directly in the digital images at a magnification of 12.5. The digital 
pictures were taken with a superimposed scale in order to help to identify the defect 
margins metrically. Using the calvarial bone thickness at the borders of the 6mm 
defects, the total area of the defect was identified. Thereafter, the number of pixels 
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within the total defect area was counted using commercial software (Adobes 
Photoshop CS). The borders of the mineralized bone within the former defects area 
were manually marked on the computer screen using a digital pen. Subsequently, the 
pixels within this marked area were counted by the software. The area fraction of 
bone was calculated as follows: 
Pixel number of the bone areaArea fraction of newly formed bone (%) =   100
Total pixel number of defect
  
 
2.9. Micro-computed tomography (µCT) 
Before embedment in methacrylate, the intact specimens stored in 70% EtOH were 
subjected to µCT 40 (Scanco Medical AG, Bassersdorf, Switzerland) as described 
previously [38]. In brief, µCT was performed using an isotropic resolution of 30mm. 
A constrained Gaussian filter (σ = 1.2 and width = 1) was used to suppress the noise 
in the volumes. Mineralized bone tissue was distinguished from non-mineralized 
tissue and graft material using two global thresholds of 19% and 30% of the 
maximum possible gray-scale value, respectively. A one-voxel thick dilation was then 
applied to the graft material, to remove partial volume elements resulting from 
digitization and filtration. At the initial defect location, a cylindrical volume of 
interest (VOI) was identified for quantitative analyses, allowing for a three-
dimensional assessment of bone volume and graft as described in Jung et al [30]. 
 
2.10. Statistical Analysis 
Mean values and standard deviation were calculated for the amount of bone formation 
within the former defect area or the former defect volume. Significant differences 
were identified by repeated measures ANOVA using the post hoc Fisher LSD (Least 
Significant Difference) test. The paired two-tailed t-test was used to compare 
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individual groups with each other. Statistical significance was set at α<0.05. Values 
were displayed as box-plots ranging from the 25th (lower quartile) to the 75th (upper 
quartile) percentile including the mean and whiskers showing the minimum and 
maximum values. Statistical analysis was performed by using a statistical software 
package (SPSS 12.0 for Windows). 
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3. Results 
3.1. TCP nanoparticles 
Spherical and highly agglomerated amorphous TCP nanoparticles in the size range of 
20-50 nm were successfully produced by flame spray synthesis as shown in earlier 
studies [31]. The as-prepared TCP particles exhibited a specific surface area of 85 ± 2 
m2 g-1 resulting in a volume averaged sphere equivalent particle diameter dBET of 22 
nm. The high phase purity of the nano-powder was confirmed by applying Fourier-
transform infrared spectroscopy (see supplementary information). Distinct, 
characteristic peaks for β-TCP were obtained after sintering at 900°C while peaks for 
impurities such as pyrophosphate (indicative of an excess of phosphate) and 
hydroxyapatite (indicative of an excess of calcium) were absent [31]. X-ray 
diffraction patterns of TCP showed a broad peak at a 2Ө value of 31.0° characteristic 
for amorphous TCP and the corresponding crystalline phase of β-TCP after sintering 
(see supplementary information). 
 
3.2. PLGA/TCP Scaffolds 
Pure and 40 wt% TCP containing PLGA scaffolds were prepared by low-temperature 
electrospinning. The three dimensional meshes consisted of homogeneous fibres 
within a diameter range of 5-10 μm as shown in the SEM images (Fig. 1). A high 
mesh porosity of 95 % was achieved which is consistent with an earlier study on low-
temperature electrospinning [22]. The fibres itself exhibited a porous structure and the 
surface of TCP particle containing fibres clearly revealed an increased roughness and 
surface area when compared to pure PLGA fibres (Fig. 1b, d). 
The scaffolds could be manually processed into a cotton wool-like nanocomposite 
allowing easy proportioning and handling as well as an advantageous adaptation of a 
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bone defect. The flexible and compressible properties of this implant material are 
demonstrated in Fig. 2. It was shown that the biomaterial expands up to 35 % of its 
compressed volume. The packing density and the TCP amount in the composite are 
variable and can be adjusted depending on the defect geometry and surgical needs. 
Misplacement during operation can be corrected by easy removal of the entire 
scaffold while granular bone substitutes are more complex to remove. 
 
3.3. In vitro bioactivity 
Previous to starting the in vivo study in rabbits the in vitro bioactivity of the cotton-
wool like nanocomposite was investigated. The change in the surface morphology 
during immersion in simulated body fluid was analyzed using scanning electron 
microscopy (SEM). After 49 hours immersion, the surface of pure polymer fibres 
became rougher (Fig. 3a) and small holes were observed due to the dissolution of the 
water soluble surfactant Tween20 and the degradation of the PLGA. In contrast, a 
continuous, nano-featured and ~1μm thick hydroxyapatite layer was deposited on the 
surface of TCP containing fibres (Fig. 3b, c) which stays in line with a previous in 
vitro study [28] on electrospun PLGA/TCP nanocomposites. 
An important aspect in developing a bone substitute material is the rate at which 
calcium phosphate mineral formation occurs under physiological ion concentration. 
Therefore, we investigated the change in mass caused by mineral deposition on the 
scaffolds. After 48 hours immersion time in simulated body fluid the mass of pure 
PLGA fibres decreased by 1% most likely due to the dissolution of the water soluble 
surfactant Tween20. On the other hand, the mass of TCP containing fibres increased 
by 18 % within the same time period. This change in mass can be mainly attributed to 
the strongly enhanced formation of hydroxyapatite on the surface of amorphous TCP 
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containing composites. These findings are in agreement with the results from a 
previous study [28] and confirm the very high in vitro bioactivity of the flexible 
biomaterial. Further it reflects the high reactivity of amorphous TCP nanoparticles 
[27, 39]. 
 
3.4. Surgical procedure 
New Zealand white rabbits were chosen for the in vivo study because they are larger 
animals than mice or rats and have a better comparability to humans. Bone 
regeneration was evaluated in four circular non-critical size defects (Ø = 6mm) in the 
cranial of totally 9 rabbits. In each animal the four defects were treated with pure 
PLGA and the highly in vitro bioactive PLGA/TCP 60:40 scaffolds and compared to 
Bio-Oss® and an untreated defect (Fig. 4). Bio-Oss® is a commercial available natural 
and osteoconductive bone substitute that is applied in dental surgery as the current 
gold standard. It consists of the mineral portion of bovine bone. From the surgical 
point of view the handling of the electrospun scaffols was easy (application like 
stuffing cotton wool into a defect geometry; see Figure 2) and compared to Bio-Oss® 
the packing density (degree of compaction when filling the defect; Figure 2) and 
mineral content in the composite material (flexibility during material preparation) can 
be adjusted depending on the defect geometry and surgical needs. Both PLGA and 
PLGA/TCP scaffolds were easily wetted with blood (Fig. 4b) favoring a 
homogeneous distribution of cells and nutrients within the bone substitute. The 
granular Bio-Oss® reference material was more challenging to apply and fix in the 
bony defect (some granules could be found outside the defect, Fig. 4b defect 3) as the 
small grains are often washed around the operation site during wound cleaning using 
physiological saline. For the treatment with granular bone substitute an average mass 
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of 35 mg per defect were used while only 10 mg and 16 mg of foreign material had to 
be applied for PLGA and PLGA/TCP respectively. 
 
3.5. Descriptive histology of the in vivo study in rabbits 
Microscopic examination of the treated cranial defects demonstrated new bone 
formation mainly originating from the bony borders directed toward the centre. 
Complete bridging of the former defects with mineralized bone occurred in 2 of the 
PLGA/TCP samples (Fig. 8a, b). Solid cortical bone developed around the Bio-Oss® 
particles (Fig. 5b, 6a, d) with a large ratio of original implant material remaining in 
the site. For the here introduced flexible materials, the newly formed bone showed a 
more spongeous (spongiosa-like) appearance in both the PLGA (Fig. 5c, 6b, e) and 
PLGA/TCP group (Fig. 5d, 6c, f). The solid appearance of the newly formed bone 
covering the Bio-Oss® particles was also evident in the Bio-Oss® group at higher 
magnifications (Fig. 6d). In the PLGA group small round holes of 3.5-5.0 µm in 
diameter were localized in the newly formed bone tissue (Fig. 6e). The same small 
holes were present in the PLGA/TCP group, but at a lower rate. In addition to the 
small round holes newly formed bone in the PLGA/TCP group contained also bigger 
holes of round to more irregular shape of 8.0 - 12.0 µm diameter. The cell density in 
the non mineralized portion appeared to be increased in the PLGA/TCP group 
compared to the PLGA group and more resembling the situation of the non 
mineralized tissue of the Bio-Oss® group (Fig. 6). No cellular infiltrate such as 
macrophages could be seen in any of the treatment groups. 
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3.6. Quantitative histomorphometric analysis 
The average area fractions of newly formed bone measured within the former defect 
amounted to 28.4±14.9% for the empty defect, 30.8±14.3% for Bio-Oss® treated 
defects, 25.1±14.6% for the PLGA treated defects, and 34.9±17.0% for the 
PLGA/TCP treated defects (Fig. 7). By using ANOVA LSD no significant difference 
between the 4 groups could be detected. Since all animals were treated with all 4 
treatment modalities, we apply the paired t-test to find a significant (p=0.07) higher 
area fraction of newly formed bone in the PLGA/TCP group compared to the PLGA 
group. Thus, the addition of the TCP nanoparticles to the electrospun PLGA 
improved its in vivo performance as bone regeneration scaffold. 
 
3.7. Micro-computed tomography (µCT) 
µCT was performed of the entire calvarial bone as shown in figure 8a, b. Pair wise 
comparison of PLGA and PLGA/TCP treated defects show that in all cases the defect 
is filled by more hard tissue in the PLGA/TCP group than in the PLGA group 
respectively (Fig 8c). In agreement with the results obtained by histomorphometry, 
the µCT showed higher values for bone volume in the PLGA/TCP than in the PLGA 
only group, although paired t-test failed to show significance (p=0.167). The µCT-
derived values were 8.42±4.35 mm3 for the untreated control group, 12.31±4.57 mm3 
for the Bio-Oss® group, 5.18±3.60 mm3 for the PLGA group, and 8.13±4.24 mm3 for 
the PLGA/TCP group. Since substantial amounts of bovine bone mineral composed 
Bio-Oss® were still present at 4 weeks (Fig 5b, 6d), the X-ray attenuation of the graft 
material was very similar to that of bone tissue. Therefore the segmentation of the 
µCT signal using global thresholds to distinguish Bio-Oss® from new bone was 
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almost impossible and could lead to an overestimation of the bone volume in the Bio-
Oss® treated control samples. 
 
4. Discussion 
The demand for flexible and easy to apply implant material for the repair of complex 
shaped bone defects increases. In this study we combined favorable properties such as 
ductility/flexibility of polymer fibers with the stability and bioactivity of the calcium 
phosphate ceramic. The performance of a flexible and cotton-wool like material as 
bone substitute was investigated in vivo in New Zealand white rabbits and compared 
with the today’s gold standard in dental surgery (Bio-Oss®) [40]. 
The investigated nanocomposite exhibits high bioactivity and meets surgical handling 
requirements by combining positive features of flame derived amorphous tricalcium 
phosphate nanoparticles and biodegradable PLGA by fiber processing through 
electrospinning. Prior to the in vivo study in rabbits, the in vitro bioactivity of the 
biomaterial was investigated and stayed in line with earlier studies on amorphous 
TCP [27] and PLGA/TCP nanocomposites [28, 39]. In vitro degradation in simulated 
body fluid showed an exceptional high degree of biomineralization for TCP 
containing samples (mass increase 18% within two days) suggesting a fast bone 
regeneration. During the implantation time, the investigated materials were observed 
to be fully compatible with the surrounding tissue without showing any significant 
adverse reactions. No inflammatory response was determined disclosing the 
biocompatibility of the used materials. Remarkable was the better wettability of the 
PLGA/TCP composite in comparison to the PLGA only material, since it could 
increase the stabilization of the blood clot needed for optimal bone regeneration [41]. 
Four weeks after implantation, descriptive histology illustrated that the Bio-Oss® 
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particles were surrounded by solid cortical bone. The large remaining of non-
degraded Bio-Oss® particles might act as a barrier to new bone formation and leads to 
an overestimation of regenerated bone in the µCT analysis. It is known that Bio-Oss® 
needs several years of implantation before it shows some slow in vivo resorption [42]. 
The newly formed bone in the defects treated with PLGA and PLGA/TCP 
nanocomposites had a spongeous structure. At this stage of bone formation the defects 
might lack mechanical stability, comparable to Bio-Oss® treated defects. However, 
the need for early stability in non-load bearing sites is of minor importance. The 
electrospun samples are not fully degraded after 4 weeks implantation (Fig. 6e and f) 
but an increased surface is noticeable. 
The incorporation of TCP nanoparticles in PLGA fibres significantly increased (p = 
0.07) the average area fraction of newly formed bone when compared to pure PLGA 
fibers (Fig. 7). This finding is in agreement with µCT results (Fig. 8). 
Based on results from the in vitro study in simulated body fluid a more pronounced 
difference in bone regeneration between the PLGA and PLGA/TCP nanocomposites 
was expected. This clearly demonstrates the importance of carrying out bioactivity 
tests besides in vitro additionally in vivo in order to get complete information about 
the performance of the bone substitute. Before first human trials, the nanocomposites 
would have to undergo further investigations in animals to evaluate the long term 
stability and clinical outcome. 
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5. Conclusions 
The advantageous use of a flexible and cotton-wool like PLGA/TCP nanocomposite 
for bone regeneration was investigated in nine New Zealand white rabbits by applying 
a circular defect model (Ø = 6 mm) in the cranium. The implant material combined a 
high in vitro bioactivity, surgical handling requirements and suggests application in 
non-load bearing, complex shaped bone defects. The area fraction of newly formed 
bone after four weeks implantation time was significantly increased in amorphous 
TCP containing PLGA fibres when compared to neat polymer electrospun scaffolds. 
The newly formed bone of these nanocomposite treated defects had a spongiosa bone 
like appearance whereas a solid cortical bone was developed in defects treated with 
Bio-Oss®, the today’s gold standard in dental surgery. A direct comparison between 
bone regeneration of treated defects with PLGA/TCP nanocomposites and Bio-Oss® 
using µCT was hindered since Bio-Oss® consists of bovine bone mineral which was 
difficult to distinguish from newly formed bone.  
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Figures 
 
 
 
Fig. 1. Scanning electron microscopy images of as electrospun scaffolds: Overview (left) and close up 
(right) of pure PLGA (a, b) and PLGA/TCP 60/40 fibres (c,d). The high surface structuring is related 
from the use of a biodegradable surfactant as a pore template. 
 
 
 
Fig. 2. Bone graft substitute materials used for the in vivo study. (a) Electrospun pure PLGA and 
PLGA/TCP scaffolds can be uncompressed in a cotton wool like appearance. (b) Simulated 
compressibility of the flexible scaffold and expansion afterwards up to 35%. (c) Bio-Oss® granules 
used as a today’s gold standard for bone regeneration. 
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Fig. 3. Scanning electron microscopy images after 2 days in vitro biomineralization in SBF: Cross 
section of a (a) pure PLGA fibre and (b) PLGA/TCP 60/40 fibre with a HAp layer of 1μm. (c) The 
deposition of nanostructured hydroxyapatite occurred only for TCP containing PLGA fibres. 
 
 
 
 
Fig. 4. Surgical procedure. (a, b) Filling of the cranial defects (Ø 6 mm) in New Zealand White rabbits: 
Pure PLGA (1), PLGA/TCP nanocomposite (2), Bio-Oss® (3), empty as a negative control (4). The 
electrospun scaffolds can be easily applied. TCP containing PLGA fibres leading to an increased 
wetability soak up the surrounding body fluid faster compared to pure PLGA fibers. 
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Fig. 5. Histological sections of the cranial defects in rabbits after 4 weeks of healing: (a) No filling as a 
negative control, (b) Bio-Oss® as a gold standard, (c) pure PLGA and (d) PLGA/TCP nanocomposite; 
scale in millimeters. 
 
 
 
 
 
 
Fig. 6: Histological sections of the cranial defects in higher magnifications: (a, d) Bio-Oss®, (b, e) pure 
PLGA and (c, f) PLGA/TCP nanocomposite; scales provided are 50 µm. The area shown in the higher 
magnification is indicated. The new formed bone in the electrospun fibrous PLGA and PLGA/TCP 
nanocomposite has a finer, more spongeous appearance compared to the more solid cortical bone 
formation with Bio-Oss®. 
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Fig. 7. Analysis of bone formation. Area fraction of newly formed bone within 
the former defect in percent of the total defect area. Histomorphometrical results (box plot with median 
and whiskers). 
 
 
 
 
Fig. 8. Micro-computed tomography. (a, b) Two examples of the μCT of the entire cranial bone are 
shown. Defect margins and treatment modalities are indicated. (c) µCT based direct intra-animal 
comparison of PLGA and PLGA/TCP treated defects of all nine animals. In all animals with the 
exception of one the closure of the PLGA/TCP treated defects is advanced compared to the PLGA 
treated defect in the same animal. 
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Supplementary Figures: 
 
 
Fig. 1: Characterization of flame spray synthesized nanoparticles: (a) Transmission electron 
micrograph of as-prepared tricalcium phosphate (TCP) nanopowder (b) Fourier-transform infrared 
spectra of as-prepared TCP nanoparticles and distinct peaks characteristic for β-TCP after sintering. 
The absence of impurities such as apatite (3600 cm-1) and calcium pyrophosphate (720 cm-1) 
confirm the purity of the material. (c) Broad XRD pattern of as-prepared amorphous TCP nanoparticles 
and peaks characteristic for β-TCP after sintering at 900°C. 
